Physician profile
Sean Francis Bak
NPI 1386746675
$79,425.57
in general payments reported to CMS, 2019-2025
11 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,311 · 2020: $18.99 · 2021: $2,769 · 2022: $13K · 2023: $18K · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Travel and Lodging: $6,401 · Food and Beverage: $2,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,990.12 |
| Travel and Lodging | $6,401.45 |
| Food and Beverage | $2,305.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $31,793.18 | 2021-2025 | Comprehensive Shoulder System, Subscapularis Repair Kits, Osseofit |
| Catalyst Orthoscience | $27,846.85 | 2022-2025 | Catalyst Total Csr, Catalyst Csr Shoulder System, R1 Reverse Total Shoulder |
| Encore Medical, Lp | $10,194.91 | 2021-2023 | Djo Surgical |
| Pinnacle, INC | $5,852.04 | 2019-2025 | |
| Stryker Corporation | $2,559.09 | 2019-2025 | Blueprint Patient Specific Instrumentation, Mako, Aequalis Perform |
| Arthrex, INC. | $1,032.10 | 2021-2025 | |
| Boston Scientific Corporation | $44.92 | 2024 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $44.36 | 2023 | Acufex Trunav, Acufex Director, Grafix |
| Wright Medical Technology, INC. | $29.70 | 2019 | |
| Medtronic, INC. | $21.38 | 2024 | Inceptiv |
| Musculoskeletal Transplant Foundation INC. | $7.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$322,533.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Bak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.